Geschreven door studenten die geslaagd zijn Direct beschikbaar na je betaling Online lezen of als PDF Verkeerd document? Gratis ruilen 4,6 TrustPilot
logo-home
Tentamen (uitwerkingen)

ICHS PHARMACOLOGY FINAL EXAM | Complete Solutions | Verified Q&A | Nursing Pharmacology | Pass Guaranteed - A+ Graded

Beoordeling
-
Verkocht
-
Pagina's
33
Cijfer
A+
Geüpload op
09-05-2026
Geschreven in
2025/2026

Pass the ICHS Pharmacology Final Exam on your first attempt with this comprehensive guide featuring complete solutions and verified Q&A! This A+ Graded resource for the International College of Health Sciences (ICHS) Pharmacology Final Exam contains verified questions with complete solutions covering all essential pharmacology concepts required for nursing and health sciences students. Featuring comprehensive coverage of pharmacokinetics (absorption, distribution, metabolism, excretion, half-life, bioavailability, first-pass effect), pharmacodynamics (receptor binding, agonists vs antagonists, therapeutic index, dose-response relationships), major drug classifications (antibiotics, cardiovascular drugs, CNS medications, endocrine drugs, respiratory drugs, GI medications, anticoagulants, analgesics, chemotherapy agents, immunosuppressants), drug interactions (CYP450 enzyme system, food-drug interactions, synergistic and antagonistic effects), adverse drug reactions and toxicity (types A, B, C, D; antidotes including naloxone, flumazenil, N-acetylcysteine, vitamin K, protamine sulfate), safe medication administration (six rights, high-alert medications, look-alike sound-alike drugs, tall man lettering, barcode scanning), dosage calculations (dimensional analysis, ratio-proportion, weight-based dosing, IV infusion rates, mcg/kg/min calculations, pediatric dosing), and patient education principles (teach-back method, literacy considerations). With detailed rationales, clinical case scenarios, drug calculation exercises, and our Pass Guarantee, this is the definitive tool for ICHS students seeking top scores on their Pharmacology Final Exam. Download now and excel in your pharmacology course with confidence!

Meer zien Lees minder
Instelling
ICHS PHARMACOLOGY
Vak
ICHS PHARMACOLOGY

Voorbeeld van de inhoud

​ICHS PHARMACOLOGY FINAL​
​EXAM 2025-2026 | Complete​
​Solutions | Verified Q&A | Nursing​
​Pharmacology | Pass Guaranteed -​
​A+ Graded​
​ ART I: MULTIPLE CHOICE (Q1–Q70)​
P
​Q1 (Anticoagulants): A patient taking warfarin has an INR of 4.5 and is actively bleeding. What​
​should the nurse administer?​
​A. Protamine sulfate​
​B. Vitamin K (phytonadione)​
​C. Fresh frozen plasma (FFP) only​
​D. Andexanet alfa​
​[CORRECT] B​
​Rationale: Vitamin K reverses warfarin effect within hours. For active bleeding, FFP (C) provides​
​immediate clotting factors but vitamin K is definitive. Protamine (A) reverses heparin; andexanet​
​(D) reverses DOACs. Clinical pearl: For life-threatening bleeding, give FFP + vitamin K.​
​Q2 (Antibiotics): A patient receiving IV vancomycin develops flushing, pruritus, and erythema on​
​the face and neck during infusion. What is the nurse's priority action?​
​A. Stop the infusion permanently and notify the provider​
​B. Slow the infusion rate and administer an antihistamine​
​C. Switch to oral vancomycin immediately​
​D. Give epinephrine 0.3 mg IM​
​[CORRECT] B​
​Rationale: These are classic signs of Red Man Syndrome, a histamine-mediated reaction to​
​rapid vancomycin infusion. Slowing the rate prevents histamine release; antihistamines manage​
​symptoms. Stopping permanently (A) is unnecessary; oral vancomycin (C) is not indicated for​
​systemic infection; epinephrine (D) is for anaphylaxis. Clinical pearl: Infuse vancomycin over at​
​least 1 hour (or per institutional protocol) and monitor trough levels.​
​Q3 (Cardiovascular): A nurse is teaching a patient newly prescribed lisinopril. Which statement​
​by the patient indicates understanding of the medication?​
​A. "I should take this medication on an empty stomach every morning."​
​B. "I need to avoid potassium-rich foods and salt substitutes."​
​C. "I can stop taking this medication once my blood pressure is normal."​

,​ . "This medication works by blocking calcium channels in my blood vessels."​
D
​[CORRECT] B​
​Rationale: ACE inhibitors like lisinopril can cause hyperkalemia; patients must avoid potassium​
​supplements and salt substitutes (potassium chloride). ACE inhibitors can be taken with food​
​(A); they should never be stopped abruptly (C); calcium channel blockers (not ACE inhibitors)​
​block calcium channels (D). Clinical pearl: Monitor for dry cough and angioedema—common​
​ACE inhibitor adverse effects.​
​Q4 (Diabetes): A patient with Type 2 diabetes is prescribed metformin. Which finding would​
​most concern the nurse before administering the medication?​
​A. Fasting blood glucose of 140 mg/dL​
​B. Serum creatinine of 2.1 mg/dL (eGFR 28 mL/min)​
​C. Hemoglobin A1c of 8.2%​
​D. Blood pressure of 138/88 mmHg​
​[CORRECT] B​
​Rationale: Metformin is contraindicated when eGFR is below 30 mL/min due to risk of lactic​
​acidosis. A fasting glucose of 140 (A) and A1c of 8.2% (C) indicate the need for treatment;​
​elevated BP (D) is not a contraindication. Clinical pearl: Hold metformin 48 hours before and​
​after iodinated contrast studies to prevent renal injury and lactic acidosis.​
​Q5 (Pain Management): A postoperative patient receiving morphine PCA reports severe​
​constipation and has not had a bowel movement in 4 days. What is the nurse's best​
​intervention?​
​A. Discontinue the PCA and switch to oral acetaminophen​
​B. Administer a stimulant laxative and increase fluid intake​
​C. Give naloxone to reverse opioid effects​
​D. Encourage the patient to bear down during bowel movements​
​[CORRECT] B​
​Rationale: Opioid-induced constipation is common; stimulant laxatives (senna, bisacodyl) plus​
​hydration are first-line. Discontinuing PCA (A) may cause uncontrolled pain; naloxone (C)​
​reverses analgesia and can precipitate withdrawal; bearing down (D) risks vagal response and​
​injury. Clinical pearl: Start a bowel regimen (stimulant + stool softener) prophylactically with all​
​opioid orders.​
​Q6 (CNS/Psych): A patient taking fluoxetine presents with agitation, hyperthermia, diaphoresis,​
​tremor, and clonus. What condition is the nurse most concerned about?​
​A. Neuroleptic malignant syndrome​
​B. Serotonin syndrome​
​C. MAOI hypertensive crisis​
​D. Benzodiazepine withdrawal​
​[CORRECT] B​
​Rationale: The triad of mental status changes, autonomic instability, and neuromuscular​
​abnormalities (clonus, hyperreflexia) defines serotonin syndrome, often caused by SSRIs alone​
​or in combination with other serotonergic agents. NMS (A) features lead-pipe rigidity and​
​elevated CK; MAOI crisis (C) features severe hypertension and headache; benzo withdrawal (D)​
​features seizures and anxiety. Clinical pearl: Never combine SSRIs with MAOIs, tramadol, or St.​
​John's wort.​

,​ 7 (Respiratory): A patient using a fluticasone/salmeterol inhaler reports white patches in the​
Q
​mouth and throat. What is the nurse's priority teaching?​
​A. Stop using the inhaler and contact the provider immediately​
​B. Rinse the mouth with water after each use and use a spacer​
​C. Switch to a short-acting beta-2 agonist only​
​D. Take an oral antifungal prophylactically​
​[CORRECT] B​
​Rationale: White patches indicate oral candidiasis (thrush) from inhaled corticosteroids. Rinsing​
​the mouth and using a spacer reduces deposition in the oropharynx. Stopping the inhaler (A) is​
​unnecessary and risks asthma/COPD exacerbation; switching to SABA only (C) is inappropriate​
​for maintenance; prophylactic antifungals (D) are not standard. Clinical pearl: Instruct patients to​
​rinse, gargle, and spit after every ICS use.​
​Q8 (GI): A patient on long-term omeprazole presents with watery diarrhea 8 times per day and​
​abdominal cramping. What is the nurse's priority action?​
​A. Increase the omeprazole dose to control acid​
​B. Obtain a stool specimen for C. difficile toxin testing​
​C. Administer loperamide immediately​
​D. Switch to an H2 blocker without testing​
​[CORRECT] B​
​Rationale: Long-term PPI use is a major risk factor for C. difficile infection due to altered gut​
​flora. Watery diarrhea with cramping is classic for C. diff. Increasing PPI (A) worsens the​
​problem; loperamide (C) is contraindicated in infectious diarrhea (toxic megacolon risk);​
​switching without testing (D) delays diagnosis. Clinical pearl: PPIs should be used at the lowest​
​effective dose for the shortest duration.​
​Q9 (Antibiotics): A patient with a penicillin allergy (anaphylaxis history) requires antibiotic​
​therapy for a severe infection. Which antibiotic is MOST appropriate?​
​A. Cefazolin​
​B. Aztreonam​
​C. Imipenem​
​D. Piperacillin-tazobactam​
​[CORRECT] B​
​Rationale: Aztreonam (a monobactam) has negligible cross-reactivity with penicillin and is safe​
​for patients with penicillin anaphylaxis. Cephalosporins (A) have ~1-2% cross-reactivity;​
​carbapenems (C) and penicillin derivatives (D) share beta-lactam rings and are contraindicated.​
​Clinical pearl: For gram-negative infections in penicillin-allergic patients, aztreonam is the​
​beta-lactam of choice.​
​Q10 (Cardiovascular): A patient on digoxin reports nausea, vomiting, and seeing yellow-green​
​halos around objects. The nurse checks the serum digoxin level. Which value indicates toxicity?​
​A. 0.5 ng/mL​
​B. 1.0 ng/mL​
​C. 1.5 ng/mL​
​D. 2.5 ng/mL​
​[CORRECT] D​

, ​ ationale: Digoxin therapeutic range is 0.5–2.0 ng/mL; levels above 2.0 ng/mL indicate toxicity.​
R
​Symptoms include GI upset, visual disturbances (yellow-green halos), and cardiac arrhythmias.​
​Clinical pearl: Hypokalemia increases digoxin toxicity risk—always check potassium levels and​
​maintain K+ > 4.0 mEq/L.​
​Q11 (Diabetes): A patient with Type 1 diabetes is prescribed insulin glargine (Lantus) and insulin​
​lispro (Humalog). When should the nurse instruct the patient to administer glargine?​
​A. 30 minutes before each meal​
​B. At bedtime only, regardless of meals​
​C. Once daily at the same time each day​
​D. Only when blood glucose is above 200 mg/dL​
​[CORRECT] C​
​Rationale: Glargine is a long-acting basal insulin with no pronounced peak, administered once​
​daily at a consistent time to provide 24-hour background insulin. It is NOT meal-dependent (A,​
​D) and can be given morning or evening (B is too restrictive). Clinical pearl: Never mix glargine​
​or detemir with other insulins in the same syringe.​
​Q12 (Anticoagulants): A patient on heparin therapy has an aPTT of 90 seconds (therapeutic​
​range: 60–80 seconds). What is the nurse's priority action?​
​A. Continue the current infusion rate and recheck in 4 hours​
​B. Hold the heparin infusion for 1 hour, then resume at a reduced rate​
​C. Administer protamine sulfate immediately​
​D. Increase the infusion rate to achieve better anticoagulation​
​[CORRECT] B​
​Rationale: An aPTT of 90 seconds is supratherapeutic; the nurse should hold the infusion briefly​
​and reduce the rate per protocol. Continuing (A) or increasing (D) risks bleeding; protamine (C)​
​is for active bleeding or severe overdose, not mild elevation. Clinical pearl: aPTT is checked 6​
​hours after any rate change; therapeutic range is typically 1.5–2.5 times control.​
​Q13 (Pain Management): A patient accidentally receives too much fentanyl and develops​
​respiratory depression with a respiratory rate of 6 breaths/min. What is the nurse's immediate​
​intervention?​
​A. Administer naloxone 0.4–2 mg IV every 2–3 minutes as needed​
​B. Give flumazenil 0.2 mg IV​
​C. Place the patient in the prone position​
​D. Administer oxygen via nasal cannula at 2 L/min only​
​[CORRECT] A​
​Rationale: Naloxone is the specific antidote for opioid-induced respiratory depression.​
​Flumazenil (B) reverses benzodiazepines; prone positioning (C) is unsafe; oxygen alone (D)​
​does not reverse the opioid effect. Clinical pearl: Titrate naloxone carefully to reverse respiratory​
​depression without causing acute withdrawal or cardiovascular instability.​
​Q14 (CNS/Psych): A patient on phenytoin for seizure control presents with swollen, bleeding​
​gums and overgrowth of gum tissue. What is this adverse effect called?​
​A. Stevens-Johnson syndrome​
​B. Gingival hyperplasia​
​C. Agranulocytosis​
​D. Osteomalacia​

Geschreven voor

Instelling
ICHS PHARMACOLOGY
Vak
ICHS PHARMACOLOGY

Documentinformatie

Geüpload op
9 mei 2026
Aantal pagina's
33
Geschreven in
2025/2026
Type
Tentamen (uitwerkingen)
Bevat
Vragen en antwoorden

Onderwerpen

$13.99
Krijg toegang tot het volledige document:

Verkeerd document? Gratis ruilen Binnen 14 dagen na aankoop en voor het downloaden kun je een ander document kiezen. Je kunt het bedrag gewoon opnieuw besteden.
Geschreven door studenten die geslaagd zijn
Direct beschikbaar na je betaling
Online lezen of als PDF

Maak kennis met de verkoper
Seller avatar
oketchnyasakwa

Maak kennis met de verkoper

Seller avatar
oketchnyasakwa Chamberlain College Of Nursing
Volgen Je moet ingelogd zijn om studenten of vakken te kunnen volgen
Verkocht
1
Lid sinds
2 maanden
Aantal volgers
0
Documenten
276
Laatst verkocht
6 dagen geleden

0.0

0 beoordelingen

5
0
4
0
3
0
2
0
1
0

Recent door jou bekeken

Waarom studenten kiezen voor Stuvia

Gemaakt door medestudenten, geverifieerd door reviews

Kwaliteit die je kunt vertrouwen: geschreven door studenten die slaagden en beoordeeld door anderen die dit document gebruikten.

Niet tevreden? Kies een ander document

Geen zorgen! Je kunt voor hetzelfde geld direct een ander document kiezen dat beter past bij wat je zoekt.

Betaal zoals je wilt, start meteen met leren

Geen abonnement, geen verplichtingen. Betaal zoals je gewend bent via iDeal of creditcard en download je PDF-document meteen.

Student with book image

“Gekocht, gedownload en geslaagd. Zo makkelijk kan het dus zijn.”

Alisha Student

Bezig met je bronvermelding?

Maak nauwkeurige citaten in APA, MLA en Harvard met onze gratis bronnengenerator.

Bezig met je bronvermelding?

Veelgestelde vragen